Global Flow Diversion Aneurysm Treatment Market 2018-2022
出 版 商：Technavio
出版日期：2018/07/02
頁 數：115頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About flow diversion aneurysm treatment
Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).
Technavio’s analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Acandis
‧ Medtronic
‧ Phenox
‧ Stryker
Market driver
‧ Increasing prevalence of IAs and associated risk factors
‧ For a full, detailed list, view our report
Market challenge
‧ Lack of awareness and access to flow diversion procedures in emerging countries
‧ For a full, detailed list, view our report
Market trend
‧ Increasing R&D focus
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).
Technavio’s analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Acandis
‧ Medtronic
‧ Phenox
‧ Stryker
Market driver
‧ Increasing prevalence of IAs and associated risk factors
‧ For a full, detailed list, view our report
Market challenge
‧ Lack of awareness and access to flow diversion procedures in emerging countries
‧ For a full, detailed list, view our report
Market trend
‧ Increasing R&D focus
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
‧ Segmentation by product
‧ Comparison by product
‧ FDS
‧ Intrasaccular flow disruption devices
‧ Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Flow diversion aneurysm treatment market in EMEA
‧ Flow diversion aneurysm treatment market in Americas
‧ Flow diversion aneurysm treatment market in APAC
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Increasing R&D focus
‧ Expanding indications
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Acandis
‧ Medtronic
‧ Phenox
‧ Stryker
‧ TERUMO CORPORATION
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Global neurovascular devices market
Exhibit 02: Global neurovascular devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global flow diversion aneurysm treatment market
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global flow diversion aneurysm treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global flow diversion aneurysm treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global flow diversion aneurysm treatment market – Market share by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global FDS market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global FDS market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global intrasaccular flow disruption devices market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global intrasaccular flow disruption devices market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global flow diversion aneurysm treatment market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Flow diversion aneurysm treatment market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Flow diversion aneurysm treatment market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top two countries in EMEA
Exhibit 31: Flow diversion aneurysm treatment market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Flow diversion aneurysm treatment market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top two countries in Americas
Exhibit 34: Flow diversion aneurysm treatment market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: Flow diversion aneurysm treatment market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top two countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Acandis – Overview
Exhibit 44: Acandis – Product segments
Exhibit 45: Acandis – Organizational developments
Exhibit 46: Acandis – Geographic focus
Exhibit 47: Acandis – Segment focus
Exhibit 48: Acandis – Key offerings
Exhibit 49: Acandis – Key customers
Exhibit 50: Medtronic – Overview
Exhibit 51: Medtronic – Business segments
Exhibit 52: Medtronic – Organizational developments
Exhibit 53: Medtronic – Geographic focus
Exhibit 54: Medtronic – Segment focus
Exhibit 55: Medtronic – Key offerings
Exhibit 56: Medtronic – Key customers
Exhibit 57: Phenox – Overview
Exhibit 58: Phenox – Product segments
Exhibit 59: Phenox – Organizational developments
Exhibit 60: Phenox – Geographic focus
Exhibit 61: Phenox – Segment focus
Exhibit 62: Phenox – Key offerings
Exhibit 63: Phenox – Key customers
Exhibit 64: Stryker – Overview
Exhibit 65: Stryker – Business segments
Exhibit 66: Stryker – Organizational developments
Exhibit 67: Stryker – Geographic focus
Exhibit 68: Stryker – Segment focus
Exhibit 69: Stryker – Key offerings
Exhibit 70: Stryker – Key customers
Exhibit 71: TERUMO CORPORATION – Overview
Exhibit 72: TERUMO CORPORATION – Business segments
Exhibit 73: TERUMO CORPORATION – Organizational developments
Exhibit 74: TERUMO CORPORATION – Geographic focus
Exhibit 75: TERUMO CORPORATION – Segment focus
Exhibit 76: TERUMO CORPORATION – Key offerings
Exhibit 77: TERUMO CORPORATION – Key customers
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
‧ Segmentation by product
‧ Comparison by product
‧ FDS
‧ Intrasaccular flow disruption devices
‧ Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Flow diversion aneurysm treatment market in EMEA
‧ Flow diversion aneurysm treatment market in Americas
‧ Flow diversion aneurysm treatment market in APAC
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Increasing R&D focus
‧ Expanding indications
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Acandis
‧ Medtronic
‧ Phenox
‧ Stryker
‧ TERUMO CORPORATION
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Global neurovascular devices market
Exhibit 02: Global neurovascular devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global flow diversion aneurysm treatment market
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global flow diversion aneurysm treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global flow diversion aneurysm treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global flow diversion aneurysm treatment market – Market share by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global FDS market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global FDS market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global intrasaccular flow disruption devices market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global intrasaccular flow disruption devices market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global flow diversion aneurysm treatment market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Flow diversion aneurysm treatment market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Flow diversion aneurysm treatment market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top two countries in EMEA
Exhibit 31: Flow diversion aneurysm treatment market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Flow diversion aneurysm treatment market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top two countries in Americas
Exhibit 34: Flow diversion aneurysm treatment market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: Flow diversion aneurysm treatment market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top two countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Acandis – Overview
Exhibit 44: Acandis – Product segments
Exhibit 45: Acandis – Organizational developments
Exhibit 46: Acandis – Geographic focus
Exhibit 47: Acandis – Segment focus
Exhibit 48: Acandis – Key offerings
Exhibit 49: Acandis – Key customers
Exhibit 50: Medtronic – Overview
Exhibit 51: Medtronic – Business segments
Exhibit 52: Medtronic – Organizational developments
Exhibit 53: Medtronic – Geographic focus
Exhibit 54: Medtronic – Segment focus
Exhibit 55: Medtronic – Key offerings
Exhibit 56: Medtronic – Key customers
Exhibit 57: Phenox – Overview
Exhibit 58: Phenox – Product segments
Exhibit 59: Phenox – Organizational developments
Exhibit 60: Phenox – Geographic focus
Exhibit 61: Phenox – Segment focus
Exhibit 62: Phenox – Key offerings
Exhibit 63: Phenox – Key customers
Exhibit 64: Stryker – Overview
Exhibit 65: Stryker – Business segments
Exhibit 66: Stryker – Organizational developments
Exhibit 67: Stryker – Geographic focus
Exhibit 68: Stryker – Segment focus
Exhibit 69: Stryker – Key offerings
Exhibit 70: Stryker – Key customers
Exhibit 71: TERUMO CORPORATION – Overview
Exhibit 72: TERUMO CORPORATION – Business segments
Exhibit 73: TERUMO CORPORATION – Organizational developments
Exhibit 74: TERUMO CORPORATION – Geographic focus
Exhibit 75: TERUMO CORPORATION – Segment focus
Exhibit 76: TERUMO CORPORATION – Key offerings
Exhibit 77: TERUMO CORPORATION – Key customers
